Southern blotting is a technique used to detect specific DNA sequences in samples of purified DNA that have been fragmented and separated according to size by gel electrophoresis. It enables researchers to identify specific genes and detect genetic disorders. Southern blotting finds applications in molecular biology, genetic research, and medical diagnosis of diseases such as cancer. The technique involves transferring electrophoresed DNA from an agarose gel to a nylon membrane for further analysis. It allows researchers to analyze how DNA is organized, how genetic material varies between species, whether a disease is inherited, and how a virus inserts itself into a host’s DNA.
The global Southern Blotting Market is estimated to be valued at US$ 3.23 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the southern blotting market is the shift from traditional southern blotting techniques to novel techniques such as fluorescence-based southern blotting. Fluorescence-based southern blotting offers advantages such as higher sensitivity, shorter processing time, and possibility of multiplex detection using fluorescently labeled probes. This technique is gaining popularity as it eliminates the use of radioisotopes and hazardous chemicals used in conventional southern blotting. Several market players are focused on developing fluorescent probes and reagents tailored for fluorescence-based southern blotting. For instance, Thermo Fisher Scientific offers a wide range of fluorescence-labeled probes and detection kits for fluorescence southern blotting. This shift towards safer techniques is expected to drive the demand for fluorescence-based southern blotting over the forecast period.
Porter’s Analysis
Threat of new entrants: The presence of large and well established players makes the entry of new players difficult in the Southern Blotting market.
Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of alternative technologies.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to the diversified supply chain in the market.
Threat of new substitutes: Availability of alternative technologies like western blotting and PCR poses a threat of substitution.
Competitive rivalry: The market is highly competitive with presence of large players.
Key Takeaways
The Global Southern Blotting Market Size is expected to witness high growth over the forecast period. The global Southern Blotting Market is estimated to be valued at US$ 3.23 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2031.
North America is expected to hold the largest market share owing to increasing research activities in the region. Asia Pacific is expected to grow at the fastest pace during the forecast period. Government initiatives have led to growth of research labs, driving the market in the region. Asia Pacific is expected to witness fastest growth over the forecast period on account of increasing healthcare investments. China and India are likely to emerge as major revenue pockets for players in the coming years.
Key players: Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation are some of the key players operating in the southern blotting market. These players are focusing on new product launches and partnerships with research institutes to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it